Jonathan B. Perlin, Pres-Clinical Services & CMO at HCA Holdings, Inc. (HCA), sold 20,000 shares at $70.66 ($1.4M) on 2014-10-29, disclosed to the SEC on 2014-10-31.
Scheduled sale ($1.4M) by Pres-Clinical Services & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCA | SELL | 2020-11-17 | $2.5M | — | Filing → |
| HCA | SELL | 2020-11-09 | $1.6M | — | Filing → |
| HCA | SELL | 2018-07-27 | $18.8M | — | Filing → |